Research indicates that without major advances in aging, radical life extension is improbable, necessitating reforms in retirement planning and life insurance.
Debiopharm, SunRock sign agreement for cancer ADCs
The partnership will advance antibody drug conjugates for hard-to-treat cancers. Credit: Pawel Giovanni Cancemi/Shutterstock.com. Debiopharm and SunRock Biopharma have signed an exclusive option and licence